SCHEMBL6272088

SCHEMBL6272088

CCOC(=O)c1cc2c(Cl)c(Oc3ccc(O)c(S(=O)(=O)NC4CC4)c3)c(C)cc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 7/20 0.43
▸ THRA P10827 3/20 0.40
▸ POLB P06746 2/20 0.37
▸ LGALS8 O00214 1/20 0.36
▸ LGALS3 P17931 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ LMNA P02545 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ HTT P42858 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MMP2 P08253 1/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ GLA P06280 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6274988 0.90 THRB (0.51) THRBTHRAPOLBLGALS8LGALS3
SCHEMBL6270967 0.90 THRB (0.51) THRBTHRAMEN1KMT2ABRD4
SCHEMBL1640579 0.81 THRB (0.59) THRBTHRALGALS8
SCHEMBL1640702 0.81 THRB (0.47) THRBTHRAL3MBTL1MEN1KMT2A
SCHEMBL6274126 0.80 THRB (0.55) THRBTHRALGALS8LGALS3ALOX15
SCHEMBL6270954 0.79 THRB (0.54) THRBTHRALGALS8LGALS3ALOX15
SCHEMBL1641445 0.78 THRB (0.58) THRBTHRAALDH1A1L3MBTL1MAPT
SCHEMBL6794754 0.78 THRB (0.46) THRBTHRAALDH1A1MEN1KMT2A
SCHEMBL1642115 0.78 THRB (0.47) THRBTHRAALDH1A1MEN1KMT2A
SCHEMBL6795305 0.77 THRB (0.47) THRBTHRAALDH1A1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1297833-B1 Indole carboxylic acids as thyroid receptor ligands PFIZER PROD INC (US) 2005-12-21 — — EP disclosed
US-6723744-B2 FOR THERAPY OF OBESITY, OVERWEIGHT CONDITION, HYPERLIPIDEMIA, GLAUCOMA, CARDIAC ARRHYTHMIAS, SKIN DISORDER, THYROID DISEASE, HYPOTHYROIDISM, THYROID CANCER, DIABETES, ATHEROSCLEROSIS, HYPERTENSION, CORONARY HEART DISEASE, HYPERCHOLESTEREMIA PFIZER, INC. 2004-04-20 — — US disclosed
US-20030078289-A1 Indole carboxylic acids as thyroid receptor ligands ASPNES GARY E (US) 2003-04-24 — — US disclosed
EP-1297833-A1 Indole carboxylic acids as thyroid receptor ligands Pfizer Products Inc. (US) 2003-04-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078289-A1 Indole carboxylic acids as thyroid receptor ligands THRA, MC1R, THRB THRB 3/4885THRA 1/4885POLB 3273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback